VC News - Page 3

Updated Apr 8, 2025 21:36 IST Photo : ET Now Digital Satish Chavva: IIT alumnus is new CEO of Oman India Joint Investment Fund IIT alumnus Satish Chavva has been appointed as

Thanks to AI, American venture funding reached its highest quarterly total in two years. Venture capital (VC) investments for the second quarter came to $55.6 billion, Reuters reported Wednesday (July 3), citing

Turbine Emerges from Stealth with $121M+ in Growth Funding to Unlock Liquidity for Private Equity and Venture Capital Investors Turbine Finance Corp., a liquidity platform driven by data science that provides credit

Consultation launched to simplify regulation for Alternative Investment Fund Managers. Changes are expected to save asset managers time and money, while enhancing the UK’s appeal as a premier destination for capital management.

Asha Ventures, a Mumbai-based venture capital firm focused on impact-driven investments in India, has secured a $10 million investment commitment from British International Investment, the United Kingdom’s development finance institution. The funding

PNN New Delhi [India], April 8: ACME Capital Venture Fund, a Rs.100 Crore fund managed by ACME Finvest–the investment arm of the renowned ACME Group–has achieved a significant milestone, setting the stage

Finnish startups raised €1.4 billion in 2024, 56% more than the previous year, boosted by larger funding rounds, despite domestic investors struggling to keep up. The Finnish Venture Capital Association has shared

A UK biotech company whose unique laboratory gut model is used to trial new drugs and foodstuffs without the need for animal testing has raised a further £750,000 from the North East Venture Fund, supported

ACME Group | Image: ACME Group ACME Capital Venture Fund, a ₹100 Crore Fund managed by ACME Finvest—the investment arm of the renowned ACME Group—has emerged as a game-changer in India’s venture

Omega Funds founder and managing director Otello Stampacchia isn’t afraid to tell it like he sees it. Back in 2022, as the biotech industry’s boom was plateauing, the brash venture capitalist told